Insulin

• 

  Subject Areas on Research

  • 13C NMR isotopomer analysis reveals a connection between pyruvate cycling and glucose-stimulated insulin secretion (GSIS). 
  • 2-Methoxyestradiol, an endogenous estradiol metabolite, differentially inhibits granulosa and endothelial cell mitosis: a potential follicular antiangiogenic regulator. 
  • 307.8: Novel Approach in Pancreatic Islet Transplantation: Acellular Vessel. 
  • 80K-H acts as a signaling bridge in intact living cells between PKCzeta and the GLUT4 translocation regulator Munc18c. 
  • A Low-Frequency Inactivating AKT2 Variant Enriched in the Finnish Population Is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk. 
  • A Pdx-1-Regulated Soluble Factor Activates Rat and Human Islet Cell Proliferation. 
  • A Systems Approach Dissociates Fructose-Induced Liver Triglyceride from Hypertriglyceridemia and Hyperinsulinemia in Male Mice. 
  • A VGF-derived peptide attenuates development of type 2 diabetes via enhancement of islet β-cell survival and function. 
  • A beta cell subset with enhanced insulin secretion and glucose metabolism is reduced in type 2 diabetes. 
  • A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. 
  • A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial. 
  • A coding and non-coding transcriptomic perspective on the genomics of human metabolic disease. 
  • A comparison of the structure of hamster pancreatic insulin and insulin extracted from a transplantable hamster islet-cell carcinoma. 
  • A controlled high-fat diet induces an obese syndrome in rats. 
  • A fundamental trade-off in covalent switching and its circumvention by enzyme bifunctionality in glucose homeostasis. 
  • A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. 
  • A high-fat diet elicits differential responses in genes coordinating oxidative metabolism in skeletal muscle of lean and obese individuals. 
  • A kinetic study of protein-protein interactions. 
  • A model of glucose-insulin homeostasis in man that incorporates the heterogeneous fast pool theory of pancreatic insulin release. 
  • A model system for the biochemical study of luteinizing hormone/chorionic gonadotropin receptor synthesis. 
  • A new strategy for studying protein kinase B and its three isoforms. Role of protein kinase B in phosphorylating glycogen synthase kinase-3, tuberin, WNK1, and ATP citrate lyase. 
  • A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. 
  • A novel receptor function for the heat shock protein Grp78: silencing of Grp78 gene expression attenuates alpha2M*-induced signalling. 
  • A novel role for the centrosomal protein, pericentrin, in regulation of insulin secretory vesicle docking in mouse pancreatic beta-cells. 
  • A physiologic role for somatostatin 28 as a regulator of insulin secretion. 
  • A primer on concentrated insulins: what an internist should know. 
  • A pyruvate cycling pathway involving cytosolic NADP-dependent isocitrate dehydrogenase regulates glucose-stimulated insulin secretion. 
  • A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. 
  • A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents. 
  • A reliable method for isolation of viable porcine islet cells. 
  • A rodent model of rapid-onset diabetes induced by glucocorticoids and high-fat feeding. 
  • A study of pituitary function in patients with idiopathic hemochromatosis. 
  • Abnormal muscle spindle innervation and large-fiber neuropathy in diabetic mice. 
  • Abnormalities in glucose tolerance are common in children with fanconi anemia and associated with impaired insulin secretion. 
  • Abnormalities of carbohydrate and lipid metabolism in Dahl rats. 
  • Abrogation of adenosine A1 receptor signalling improves metabolic regulation in mice by modulating oxidative stress and inflammatory responses. 
  • Acetaminophen normalizes glucose homeostasis in mouse models for diabetes. 
  • Activated protein C preserves functional islet mass after intraportal transplantation: a novel link between endothelial cell activation, thrombosis, inflammation, and islet cell death. 
  • Activated α2-macroglobulin binding to human prostate cancer cells triggers insulin-like responses. 
  • Activation of Nrf2 Is Required for Normal and ChREBPα-Augmented Glucose-Stimulated β-Cell Proliferation. 
  • Activation of direct and indirect pathways of glycogen synthesis by hepatic overexpression of protein targeting to glycogen. 
  • Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease. 
  • Activation of the parasympathetic nervous system is necessary for normal meal-induced insulin secretion in rhesus macaques. 
  • Active involvement of PKC for insulin-mediated rates of muscle protein synthesis in Zucker rats. 
  • Acute administration of unacylated ghrelin has no effect on Basal or stimulated insulin secretion in healthy humans. 
  • Acute loss of adipose tissue-derived adiponectin triggers immediate metabolic deterioration in mice. 
  • Adenovirus-mediated expression of the catalytic subunit of glucose-6-phosphatase in INS-1 cells. Effects on glucose cycling, glucose usage, and insulin secretion. 
  • Adenovirus-mediated overexpression of uncoupling protein-2 in pancreatic islets of Zucker diabetic rats increases oxidative activity and improves beta-cell function. 
  • Adenylosuccinate Is an Insulin Secretagogue Derived from Glucose-Induced Purine Metabolism. 
  • Adiponectin is essential for lipid homeostasis and survival under insulin deficiency and promotes β-cell regeneration. 
  • Adiponectin is not altered with exercise training despite enhanced insulin action. 
  • Adrenal medullary storage vesicles of the spontaneously hypertensive rat. 
  • Adrenergic desensitization in left ventricle from streptozotocin diabetic swine. 
  • Adverse Cardiovascular Response to Aerobic Exercise Training: Is This a Concern? 
  • Adverse metabolic response to regular exercise: is it a rare or common occurrence? 
  • Age-dependent impairment of glucose tolerance in the 3xTg-AD mouse model of Alzheimer's disease. 
  • Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. 
  • Alcohol-associated risks for young adults with Type 1 diabetes: a narrative review. 
  • All-or-none secretion of adrenal medullary storage vesicle contents in the rat. 
  • Alprazolam reduces stress hyperglycemia in ob/ob mice. 
  • Alterations in calcium channel currents underlie defective insulin secretion in a transgenic mouse. 
  • Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones. 
  • Altered islet function and insulin clearance cause hyperinsulinemia in gastric bypass patients with symptoms of postprandial hypoglycemia. 
  • Alzheimer’s disease: the new promise. 
  • Analysis of myocardial function in orthotopic cardiac allografts after prolonged storage in UW solution. 
  • Analysis of sites phosphorylated on acetyl-CoA carboxylase in response to insulin in isolated adipocytes. Comparison with sites phosphorylated by casein kinase-2 and the calmodulin-dependent multiprotein kinase. 
  • Analysis of the role of E2A-encoded proteins in insulin gene transcription. 
  • Animal model for maturity-onset diabetes of the young generated by disruption of the mouse glucokinase gene. 
  • Ankyrin-B metabolic syndrome combines age-dependent adiposity with pancreatic β cell insufficiency. 
  • Antiangiogenic agents protect liver sinusoidal lining cells from cold preservation injury in rat liver transplantation. 
  • Antidiabetic therapies affect risk of pancreatic cancer. 
  • Apolipoprotein E4 Impairs Neuronal Insulin Signaling by Trapping Insulin Receptor in the Endosomes. 
  • Aquaglyceroporin AQP9: solute permeation and metabolic control of expression in liver. 
  • Are stress eaters at risk for the metabolic syndrome? 
  • Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness. 
  • Assessing the Impact of an Order Panel Utilizing Weight-Based Insulin and Standardized Monitoring of Blood Glucose for Patients With Hyperkalemia. 
  • Association between Bout Duration of Physical Activity and Health: Systematic Review. 
  • Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial. 
  • Association of Adverse Pregnancy Outcomes With Glyburide vs Insulin in Women With Gestational Diabetes. 
  • Association of levels of fasting glucose and insulin with rare variants at the chromosome 11p11.2-MADD locus: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Targeted Sequencing Study. 
  • Association of muscle mass measured by D3-Creatine (D3Cr), sarcopenic obesity, and insulin-glucose homeostasis in postmenopausal women. 
  • Association of protein kinase C(lambda) with adducin in 3T3-L1 adipocytes. 
  • Attenuation of counterregulatory responses to recurrent hypoglycemia by active thalamic inhibition: a mechanism for hypoglycemia-associated autonomic failure. 
  • Automated Insulin Delivery Systems: Hopes and Expectations of Family Members. 
  • Automated bolus advisor control and usability study (ABACUS): does use of an insulin bolus advisor improve glycaemic control in patients failing multiple daily insulin injection (MDI) therapy? [NCT01460446]. 
  • BARI 2D: A Reanalysis Focusing on Cardiovascular Events. 
  • BMI, RQ, diabetes, and sex affect the relationships between amino acids and clamp measures of insulin action in humans. 
  • Basal and stimulated serum growth hormone concentrations in inflammatory bowel disease. 
  • Baseline predictors of A1C reduction in adults using sensor-augmented pump therapy or multiple daily injection therapy: the STAR 3 experience. 
  • Be Careful What You Ask For: Effects of Benefit Descriptions on Diabetes Patients' Benefit-Risk Tradeoff Preferences. 
  • Bed rest worsens impairments in fat and glucose metabolism in older, overweight adults. 
  • Behavioral manipulation of the diabetic phenotype in ob/ob mice. 
  • Beta cell monoamines: further evidence for their role in modulating insulin secretion. 
  • Beta-cell sensitivity to glucose is impaired after gastric bypass surgery. 
  • Beta-cell sensitivity to insulinotropic gut hormones is reduced after gastric bypass surgery. 
  • Big or fast: two strategies in the developmental control of body size. 
  • Biliary response to glucagon and insulin following hepatic transplantation in humans. 
  • Biliary response to glucagon in humans. 
  • Biochemical mechanism of lipid-induced impairment of glucose-stimulated insulin secretion and reversal with a malate analogue. 
  • Biomedicine. Insulin resistance takes a trip through the ER. 
  • Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass. 
  • Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes. 
  • Bombyxin is a growth factor for wing imaginal disks in Lepidoptera. 
  • Both insulin and epidermal growth factor stimulate lipogenesis and acetyl-CoA carboxylase activity in isolated adipocytes. Importance of homogenization procedure in avoiding artefacts in acetyl-CoA carboxylase assay. 
  • Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats. 
  • Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism. 
  • Branched-Chain Amino Acids and Insulin Metabolism: The Insulin Resistance Atherosclerosis Study (IRAS). 
  • Bypassing the duodenum does not improve insulin resistance associated with diet-induced obesity in rodents. 
  • C-terminal deletion of the atrophin-1 protein results in growth retardation but not neurodegeneration in mice. 
  • CCK and other peptides modulate hypothalamic norepinephrine release in the rat: dependence on hunger or satiety. 
  • Caffeine impairs glucose metabolism in type 2 diabetes. 
  • Calmodulin in endocrine cells and its multiple roles in hormone action. 
  • Calmodulin overexpression causes Ca(2+)-dependent apoptosis of pancreatic beta cells, which can be prevented by inhibition of nitric oxide synthase. 
  • Calmodulin-induced early-onset diabetes in transgenic mice. 
  • Capsule Commentary on Min et al., Comparative Effectiveness of Insulin versus Combination Sulfonylurea and Insulin: a Cohort Study of Veterans with Type 2 Diabetes: How to Escalate Therapy for Patients who Fail Sulfonylureas. 
  • Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. 
  • Cardiometabolic Health in Submariners Returning from a 3-Month Patrol. 
  • Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum. 
  • Cdc37/Hsp90 protein-mediated regulation of IRE1α protein activity in endoplasmic reticulum stress response and insulin synthesis in INS-1 cells. 
  • Cellular engineering and gene therapy strategies for insulin replacement in diabetes. 
  • Central and peripheral effects of insulin/IGF-1 signaling in aging and cancer: antidiabetic drugs as geroprotectors and anticarcinogens. 
  • Central and sympatho-adrenal responses to insulin in adult and neonatal rats. 
  • Central infusion of glucagon-like peptide-1-(7-36) amide (GLP-1) receptor antagonist attenuates lithium chloride-induced c-Fos induction in rat brainstem. 
  • Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. 
  • ChREBP regulates fructose-induced glucose production independently of insulin signaling. 
  • Changes in depressive symptoms and glycemic control in diabetes mellitus. 
  • Changes in hunger and fullness in relation to gut peptides before and after 8 weeks of alternate day fasting. 
  • Characterization of a putative insulin-responsive element and its binding protein(s) in rat angiotensinogen gene promoter: regulation by glucose and insulin. 
  • Characterization of a selective inhibitor of inositol hexakisphosphate kinases: use in defining biological roles and metabolic relationships of inositol pyrophosphates. 
  • Characterization of mediators of insulin action. 
  • Characterization of the insulinotropic potency of polyunsaturated fatty acids. 
  • Cholinergic augmentation of insulin release requires ankyrin-B. 
  • Chronic suppression of acetyl-CoA carboxylase 1 in beta-cells impairs insulin secretion via inhibition of glucose rather than lipid metabolism. 
  • Classically conditioned enhancement of hyperinsulinemia in the ob/ob mouse. 
  • Clinical Effects of Balanced Crystalloids vs Saline in Adults With Diabetic Ketoacidosis: A Subgroup Analysis of Cluster Randomized Clinical Trials. 
  • Clinical Impact of Diabetes Mellitus on Outcomes After Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. 
  • Clinical Phenotypes in Patients With Type 2 Diabetes Mellitus: Characteristics, Cardiovascular Outcomes and Treatment Strategies. 
  • Clinical pearls and strategies to optimize patient outcomes. 
  • Clinical pharmacology of insulin confounds stroke trials. 
  • Clinical uses of gut peptides. 
  • Clinical, Hormonal, and Metabolic Parameters in Women with Subclinical Hypothyroidism and Polycystic Ovary Syndrome: A Cross-Sectional Study. 
  • Cloned mice have an obese phenotype not transmitted to their offspring. 
  • Closing the Loop in Adults, Children and Adolescents With Suboptimally Controlled Type 1 Diabetes Under Free Living Conditions: A Psychosocial Substudy. 
  • Cocaine-exposed preterm neonates show behavioral and hormonal differences. 
  • Cognitive function and anticoagulation control in patients with atrial fibrillation. 
  • Combination insulin and sulfonylurea therapy in insulin-requiring type 2 diabetes mellitus. 
  • Comparison of an Electronic Glycemic Management System Versus Provider-Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting. 
  • Comparison of one-year outcomes following coronary artery stenting in diabetic versus nondiabetic patients (from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy [ESPRIT] Trial). 
  • Compensatory responses to pyruvate carboxylase suppression in islet beta-cells. Preservation of glucose-stimulated insulin secretion. 
  • Competing paradigms of obesity pathogenesis: energy balance versus carbohydrate-insulin models. 
  • Complexation hydrogels for oral protein delivery: an in vitro assessment of the insulin transport-enhancing effects following dissolution in simulated digestive fluids. 
  • Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor gamma activation has coordinate effects on gene expression in multiple insulin-sensitive tissues. 
  • Computerized knowledge management in diabetes care. 
  • Constitutive expression of placental lactogen in pancreatic beta cells: effects on cell morphology, growth, and gene expression. 
  • Consumption of a high-fat diet alters the homeostatic regulation of energy balance. 
  • Consumption of a high-fat diet induces central insulin resistance independent of adiposity. 
  • Consumption of meat is associated with higher fasting glucose and insulin concentrations regardless of glucose and insulin genetic risk scores: a meta-analysis of 50,345 Caucasians. 
  • Contraction of insulin-resistant muscle normalizes insulin action in association with increased mitochondrial activity and fatty acid catabolism. 
  • Contributions of fat and protein to the incretin effect of a mixed meal. 
  • Control of expression of insulin resistance and hyperglycemia by different genetic factors in diabetic C57BL/6J mice. 
  • Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. 
  • Control of phenylalanine hydroxylase synthesis in tissue culture by serum and insulin. 
  • Control of voltage-gated potassium channel Kv2.2 expression by pyruvate-isocitrate cycling regulates glucose-stimulated insulin secretion. 
  • Controlled release of biologics for the treatment of type 2 diabetes. 
  • Cooperation between brain and islet in glucose homeostasis and diabetes. 
  • Coordinate regulation of the alpha(2)-macroglobulin signaling receptor and the low density lipoprotein receptor-related protein/alpha(2)-macroglobulin receptor by insulin. 
  • Cost-effectiveness of sensor-augmented pump therapy in adults with type 1 diabetes in the United States. 
  • Critical appraisal of four IL-6 immunoassays. 
  • Current practices in gestational diabetes mellitus diagnosis and management in the United States: survey of maternal-fetal medicine specialists. 
  • Cytoplasmic polyadenylation element binding protein deficiency stimulates PTEN and Stat3 mRNA translation and induces hepatic insulin resistance. 
  • Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial. 
  • Defective glucose-stimulated insulin release from perifused islets of C57BL/6J mice. 
  • Defective glycolysis and calcium signaling underlie impaired insulin secretion in a transgenic mouse. 
  • Deintensification of Treatment With Sulfonylurea and Insulin After Severe Hypoglycemia Among Older Adults With Diabetes. 
  • Delayed apoptosis allows islet β-cells to implement an autophagic mechanism to promote cell survival. 
  • Deletion of GαZ protein protects against diet-induced glucose intolerance via expansion of β-cell mass. 
  • Deletion of V335 from the L2 domain of the insulin receptor results in a conformationally abnormal receptor that is unable to bind insulin and causes Donohue's syndrome in a human subject. 
  • Deletion of the glucagon receptor gene before and after experimental diabetes reveals differential protection from hyperglycemia. 
  • Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. 
  • Depression in persons with diabetes by age and antidiabetic treatment: a cross-sectional analysis with data from the Hordaland Health Study. 
  • Determinants of successful glycemic control among participants in the BARI 2D trial: a post-hoc analysis. 
  • Development of postglucoprivic insulin-induced suckling and feeding in rats. 
  • Developmental mechanisms of body size and wing-body scaling in insects. 
  • Diabetes Technology and the Human Factor. 
  • Diabetes medication regimens and patient clinical characteristics in the national patient-centered clinical research network, PCORnet. 
  • Diabetes mellitus and insulin therapy in infective endocarditis. 
  • Diabetic biomarkers and the risk of proximal or distal gastric cancer. 
  • Diabetic liver injury from streptozotocin is regulated through the caspase-8 homolog cFLIP involving activation of JNK2 and intrahepatic immunocompetent cells. 
  • Diazoxide restores beta3-adrenergic receptor function in diet-induced obesity and diabetes. 
  • Diet-induced type II diabetes in C57BL/6J mice. 
  • Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance). 
  • Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. 
  • Dietary regulation of glucose-dependent insulinotropic peptide (GIP) gene expression in rat small intestine. 
  • Dietary treatment of diabetes mellitus in the pre-insulin era (1914-1922). 
  • Differential AMPK phosphorylation by glucagon and metformin regulates insulin signaling in human hepatic cells. 
  • Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans. 
  • Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. 
  • Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling. 
  • Differential effects of overexpressed glucokinase and hexokinase I in isolated islets. Evidence for functional segregation of the high and low Km enzymes. 
  • Differential glycemic effects of morphine in diabetic and normal mice. 
  • Digital Health: Tracking Physiomes and Activity Using Wearable Biosensors Reveals Useful Health-Related Information 
  • Diminished acyl-CoA synthetase isoform 4 activity in INS 832/13 cells reduces cellular epoxyeicosatrienoic acid levels and results in impaired glucose-stimulated insulin secretion. 
  • Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects. 
  • Disinhibited eating and weight-related insulin mismanagement among individuals with type 1 diabetes. 
  • Disruption of Acetyl-Lysine Turnover in Muscle Mitochondria Promotes Insulin Resistance and Redox Stress without Overt Respiratory Dysfunction. 
  • Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. 
  • Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling. 
  • Does ghrelin explain accelerated gastric emptying in the early stages of diabetes mellitus? 
  • Downregulation of carnitine acyl-carnitine translocase by miRNAs 132 and 212 amplifies glucose-stimulated insulin secretion. 
  • Dynamic changes in retinal vessel diameter during acute hyperglycemia in type 1 diabetes. 
  • Early pregnancy insulin resistance and subsequent gestational diabetes mellitus. 
  • Early-life starvation alters lipid metabolism in adults to cause developmental pathology in Caenorhabditis elegans. 
  • Early-onset repeated dieting reduces food intake and body weight but not adiposity in dietary-obese female rats. 
  • Education on the glycemic index of foods fails to improve treatment outcomes in a behavioral weight loss program. 
  • Effect of Alternate-Day Fasting on Weight Loss, Weight Maintenance, and Cardioprotection Among Metabolically Healthy Obese Adults: A Randomized Clinical Trial. 
  • Effect of IGFBP-3 on IGF- and IGF-analogue-induced insulin-like growth factor-I receptor (IGFIR) signalling. 
  • Effect of Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding on branched-chain amino acid metabolism. 
  • Effect of cyclic nucleotides on the induction of ornithine decarboxylase in BHK cells by serum and insulin. 
  • Effect of endogenous GLP-1 on insulin secretion in type 2 diabetes. 
  • Effect of excessive gestational weight gain on insulin sensitivity and insulin kinetics in women with overweight/obesity. 
  • Effect of exercise intensity and volume on persistence of insulin sensitivity during training cessation. 
  • Effect of fatty acids on insulin release: role of chain length and degree of unsaturation. 
  • Effect of glucagon and insulin upon biliary lipid secretion. 
  • Effect of glycemia on plasma incretins and the incretin effect during oral glucose tolerance test. 
  • Effect of growth conditions on the activity of ornithine decarboxylase in cultured hepatoma cells. II. Effect of serum and insulin. 
  • Effect of intracerebroventricular infusion of insulin on glucose-dependent insulinotropic peptide in dogs. 
  • Effect of predicted low suspend pump treatment on improving glycaemic control and quality of sleep in children with type 1 diabetes and their caregivers: the QUEST randomized crossover study. 
  • Effect of short-term exercise training on insulin-stimulated PI 3-kinase activity in middle-aged men. 
  • Effect of somatostatin-28 on dynamics of insulin secretion in perfused rat pancreas. 
  • Effect of the volume and intensity of exercise training on insulin sensitivity. 
  • Effect of voluntary exercise on peripheral tissue glucocorticoid receptor content and the expression and activity of 11beta-HSD1 in the Syrian hamster. 
  • Effectively identifying the inpatient with hyperglycemia to increase patient care and lower costs. 
  • Effects of Extended-Release Niacin Added to Simvastatin/Ezetimibe on Glucose and Insulin Values in AIM-HIGH. 
  • Effects of GLP-1 and GIP on Islet Function in Glucose-Intolerant, Pancreatic-Insufficient Cystic Fibrosis. 
  • Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1- (9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans. 
  • Effects of Roux-en-Y gastric bypass or diabetes support and education on insulin sensitivity and insulin secretion in morbidly obese patients with type 2 diabetes. 
  • Effects of Vitamin D Supplementation on Insulin Sensitivity and Secretion in Prediabetes. 
  • Effects of aerobic training with and without weight loss on insulin sensitivity and lipids. 
  • Effects of amino acids and gastric inhibitory polypeptide on insulin release in dogs. 
  • Effects of an ad libitum, high carbohydrate diet and aerobic exercise training on insulin action and muscle metabolism in older men and women. 
  • Effects of bombesin on fasting bile formation. 
  • Effects of branched-chain amino acids on glucose metabolism in obese, prediabetic men and women: a randomized, crossover study. 
  • Effects of exercise training alone vs a combined exercise and nutritional lifestyle intervention on glucose homeostasis in prediabetic individuals: a randomised controlled trial. 
  • Effects of experimental diabetes on adrenergic and cholinergic receptors of rat myocardium. 
  • Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release. 
  • Effects of glucagon-like peptide 1 on the hepatic glucose metabolism. 
  • Effects of glucagonlike peptide I-(7-36) on release of insulin, glucagon, and somatostatin by rat pancreatic islet cell monolayer cultures. 
  • Effects of insulin-like growth factors I and II and insulin on the immortalized hypothalamic GTI-7 cell line. 
  • Effects of lactogen resistance and GH deficiency on mouse metabolism: pancreatic hormones, adipocytokines, and expression of adiponectin and insulin receptors. 
  • Effects of leukocyte depleted blood on renal reperfusion injury in a porcine model. 
  • Effects of low-carbohydrate diets versus low-fat diets on metabolic risk factors: a meta-analysis of randomized controlled clinical trials. 
  • Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. 
  • Effects of moderate and high glycemic index meals on metabolism and exercise performance. 
  • Effects of modulation of glycerol kinase expression on lipid and carbohydrate metabolism in human muscle cells. 
  • Effects of morphine on the rat adrenal medulla. 
  • Effects of potassium supplements on glucose metabolism in African Americans with prediabetes: a pilot trial. 
  • Effects of relaxation therapy on patients with type I diabetes mellitus. 
  • Effects of reserpine on the content and properties of rat adrenal medullary storage vesicles. 
  • Effects of short-term very low-calorie diet on intramyocellular lipid and insulin sensitivity in nondiabetic and type 2 diabetic subjects. 
  • Effects of the dietary approaches to stop hypertension diet alone and in combination with exercise and caloric restriction on insulin sensitivity and lipids. 
  • Efficacy and safety of acarbose in metformin-treated patients with type 2 diabetes. 
  • Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial. 
  • Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology. 
  • Elevated beta-cell calmodulin produces a unique insulin secretory defect in transgenic mice. 
  • Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons. 
  • Endogenous somatostatin-28 modulates postprandial insulin secretion. Immunoneutralization studies in baboons. 
  • Endurance exercise training increases adipose tissue glucocorticoid exposure: adaptations that facilitate lipolysis. 
  • Engineered cell lines for insulin replacement in diabetes: current status and future prospects. 
  • Engineering of glucose-stimulated insulin secretion and biosynthesis in non-islet cells. 
  • Engineering of glycerol-stimulated insulin secretion in islet beta cells. Differential metabolic fates of glucose and glycerol provide insight into mechanisms of stimulus-secretion coupling. 
  • Enhanced Glucose Control Following Vertical Sleeve Gastrectomy Does Not Require a β-Cell Glucagon-Like Peptide 1 Receptor. 
  • Enhanced cAMP protein kinase A signaling determines improved insulin secretion in a clonal insulin-producing beta-cell line (INS-1 832/13). 
  • Enhanced cardiac preservation with oxygenated University of Wisconsin solution. 
  • Enhancement of endocrine pancreatic secretions by essential fatty acids. 
  • Enhancing insulin-use safety in hospitals: Practical recommendations from an ASHP Foundation expert consensus panel. 
  • Enteral enhancement of glucose disposition by both insulin-dependent and insulin-independent processes. A physiological role of glucagon-like peptide I. 
  • Enteroinsular signaling: perspectives on the role of the gastrointestinal hormones glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide in normal and abnormal glucose metabolism. 
  • Epidermal growth factor enhances [125I]iodo-follicle-stimulating hormone binding by cultured porcine granulosa cells. 
  • Epidermal growth factor stimulates glycogen synthesis in fetal rat hepatocytes: comparison with the glycogenic effects of insulin-like growth factor I and insulin. 
  • Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors. 
  • Evaluation of solutions for small intestinal preservation. Biochemical changes as a function of storage time. 
  • Evidence for a novel insulin-like growth factor (IGF)-dependent protease regulating IGF-binding protein-4 in dermal fibroblasts. 
  • Evidence for metabolic and endocrine abnormalities in subjects recovered from anorexia nervosa. 
  • Evidence for selective release of rodent islet amyloid polypeptide through the constitutive secretory pathway. 
  • Evidence from a single individual that increased plasma GLP-1 and GLP-1-stimulated insulin secretion after gastric bypass are independent of foregut exclusion. 
  • Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. 
  • Evidence that activation of acetyl-CoA carboxylase by insulin in adipocytes is mediated by a low-Mr effector and not by increased phosphorylation. 
  • Exaggerated peripheral responses to catecholamines contributes to stress-induced hyperglycemia in the ob/ob mouse. 
  • Exaggeration of postprandial hyperglycemia in patients with type 2 diabetes by administration of caffeine in coffee. 
  • Exercise and weight loss reduce blood pressure in men and women with mild hypertension: effects on cardiovascular, metabolic, and hemodynamic functioning. 
  • Exercise increases muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance. 
  • Exercise training, lipid regulation, and insulin action: a tangled web of cause and effect. 
  • Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation. 
  • Experience with combined hepatic, pancreaticoduodenal, and renal procurement with UW solution. 
  • Experiences of closed-loop insulin delivery among pregnant women with Type 1 diabetes. 
  • Exploring the Role of Insulin Signaling in Relative Growth: A Case Study on Wing-Body Scaling in Lepidoptera. 
  • Expression and glycogenic effect of glycogen-targeting protein phosphatase 1 regulatory subunit GL in cultured human muscle. 
  • Expression of glucokinase in cultured human muscle cells confers insulin-independent and glucose concentration-dependent increases in glucose disposal and storage. 
  • Expression of normal and novel glucokinase mRNAs in anterior pituitary and islet cells. 
  • Expression of reg/PSP, a pancreatic exocrine gene: relationship to changes in islet beta-cell mass. 
  • Expression of the transcription factor STAT-1 alpha in insulinoma cells protects against cytotoxic effects of multiple cytokines. 
  • Expression, enzyme activity, and subcellular localization of mammalian target of rapamycin in insulin-responsive cells. 
  • Extensive diversity in circadian regulation of plasma lipids and evidence for different circadian metabolic phenotypes in humans. 
  • Factors associated with insulin and narcotic independence after islet autotransplantation in patients with severe chronic pancreatitis. 
  • Factors associated with non-adherence to insulin and non-insulin medications in patients with poorly controlled diabetes. 
  • Factors associated with persistent poorly controlled diabetes mellitus: clues to improving management in patients with resistant poor control. 
  • Failure of 2-deoxy-D-glucose to stimulate feeding in deermice. 
  • Failure of genetically selected miniature swine to model NIDDM. 
  • Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators. 
  • Fasting and postprandial concentrations of somatostatin-28 and somatostatin-14 in type II diabetes in men. 
  • Fatty acid oxidation and insulin action: when less is more. 
  • Fear of hypoglycaemia in parents of young children with type 1 diabetes: a systematic review. 
  • Fish oil slows prostate cancer xenograft growth relative to other dietary fats and is associated with decreased mitochondrial and insulin pathway gene expression. 
  • Follicle-stimulating hormone-mediated induction of functional luteinizing hormone/human chorionic gonadotropin receptors during monolayer culture of porcine granulosa cells. 
  • Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism. 
  • Food perception without ingestion leads to metabolic changes and irreversible developmental arrest in C. elegans. 
  • Foxa1-deficient mice exhibit impaired insulin secretion due to uncoupled oxidative phosphorylation. 
  • Function of microtubules under inadequate protein diet. 
  • Functional genomics of the beta-cell: short-chain 3-hydroxyacyl-coenzyme A dehydrogenase regulates insulin secretion independent of K+ currents. 
  • Functional photoacoustic microscopy of diabetic vasculature. 
  • G(s)alpha deficiency in skeletal muscle leads to reduced muscle mass, fiber-type switching, and glucose intolerance without insulin resistance or deficiency. 
  • GLP-1 Receptor Blockade Reduces Stimulated Insulin Secretion in Fasted Subjects With Low Circulating GLP-1. 
  • GLP-1 agonist therapy for advanced heart failure with reduced ejection fraction: design and rationale for the functional impact of GLP-1 for heart failure treatment study. 
  • GLP-1 and energy balance: an integrated model of short-term and long-term control. 
  • GLUT-2 gene transfer into insulinoma cells confers both low and high affinity glucose-stimulated insulin release. Relationship to glucokinase activity. 
  • GPR92 activation in islet macrophages controls β cell function in a diet-induced obesity model. 
  • Galphaz negatively regulates insulin secretion and glucose clearance. 
  • Gastric bypass alters both glucose-dependent and glucose-independent regulation of islet hormone secretion. 
  • Gastric bypass significantly improves quality of life in morbidly obese patients with type 2 diabetes. 
  • Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans. 
  • Gastric emptying, glucose tolerance, and insulin response after duodenojejunostomy. 
  • Gender-specific correlates of leptin with hypertension-related phenotypes in African Americans. 
  • Genetic engineering of a suboptimal islet graft with A20 preserves beta cell mass and function. 
  • Genetic studies of body mass index yield new insights for obesity biology. 
  • Genetic variation in aldosterone synthase predicts plasma glucose levels. 
  • Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. 
  • Genomewide search for type 2 diabetes susceptibility genes in four American populations. 
  • Ghrelin Impairs Prandial Glucose Tolerance and Insulin Secretion in Healthy Humans Despite Increasing GLP-1. 
  • Ghrelin regulation of glucose metabolism. 
  • Ghrelin stimulation of growth hormone isoforms: parallel secretion of total and 20-kDa growth hormone and relation to insulin sensitivity in healthy humans. 
  • Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans. 
  • Giant two-dimensional gel electrophoresis: methodological update and comparison with intermediate-format gel systems. 
  • Glucagon in insulin coma therapy: its use in a small psychiatric unit of a general hospital. 
  • Glucagon lowers glycemia when β-cells are active. 
  • Glucagon or insulin suppressed biliary lipid excretion in dog and man. 
  • Glucagon-like peptide 1 (GLP-1). 
  • Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal. 
  • Glucagon-like peptide 1: continued advances, new targets and expanding promise as a model therapeutic. 
  • Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes. 
  • Glucokinase and glucose transporter expression in liver and islets: implications for control of glucose homoeostasis. 
  • Glucokinase gene transfer to skeletal muscle of diabetic Zucker fatty rats improves insulin-sensitive glucose uptake. 
  • Glucose Activates Vagal Control of Hyperglycemia and Inflammation in Fasted Mice. 
  • Glucose Uptake and Insulin Response in Tissue-engineered Human Skeletal Muscle. 
  • Glucose and lipid effects of the ileal apical sodium-dependent bile acid transporter inhibitor GSK2330672: double-blind randomized trials with type 2 diabetes subjects taking metformin. 
  • Glucose control in hospitalized patients. 
  • Glucose down-regulates the expression of the peroxisome proliferator-activated receptor-alpha gene in the pancreatic beta -cell. 
  • Glucose stimulates and potentiates islet amyloid polypeptide secretion by the B-cell. 
  • Glucose tolerance, insulin secretion, and insulin sensitivity in children and adolescents with cystic fibrosis and no prior history of diabetes. 
  • Glycemic Control and Insulin Treatment Alter Fracture Risk in Older Men With Type 2 Diabetes Mellitus. 
  • Glycemic Variability and Its Impact on Quality of Life in Adults With Type 1 Diabetes. 
  • Glycemic response to stress is altered in euglycemic Pima Indians. 
  • Glycerate from intestinal fructose metabolism induces islet cell damage and glucose intolerance. 
  • Glycogen synthase: a putative locus for diet-induced hyperglycemia. 
  • Glycophase glass revisited: protein adsorption and cell growth on glass surfaces bearing immobilized glycerol monosaccharides. 
  • Granulosa cell differentiation in vitro: effect of insulin on growth and functional integrity. 
  • Growth retardation in the Lesch-Nyhan syndrome. 
  • Gut hormone pharmacology of a novel GPR119 agonist (GSK1292263), metformin, and sitagliptin in type 2 diabetes mellitus: results from two randomized studies. 
  • Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. 
  • Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression. 
  • Hepatocyte Smoothened Activity Controls Susceptibility to Insulin Resistance and Nonalcoholic Fatty Liver Disease. 
  • Heterogeneity of healthy aging: comparing long-lived families across five healthy aging phenotypes of blood pressure, memory, pulmonary function, grip strength, and metabolism. 
  • Higher high-density lipoprotein cholesterol in African-American women with polycystic ovary syndrome compared with Caucasian counterparts. 
  • Higher magnesium intake is associated with lower fasting glucose and insulin, with no evidence of interaction with select genetic loci, in a meta-analysis of 15 CHARGE Consortium Studies. 
  • History of and factors associated with diabetic foot ulcers in Norway: the Nord-Trøndelag Health Study. 
  • History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium. 
  • Holistic Impact of Closed-Loop Technology on People With Type 1 Diabetes. 
  • Home Use of an Artificial Beta Cell in Type 1 Diabetes. 
  • Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study. 
  • Hormonal activation of ornithine decarboxylase in embryonic chick pelvic cartilage. 
  • Hormonal and metabolic effects of carbohydrate restriction in children with Prader-Willi syndrome. 
  • Hormonal control of growth in the wing imaginal disks of Junonia coenia: the relative contributions of insulin and ecdysone. 
  • Hormonal stimulation of avian embryonic cartilage growth in vitro: histologic and ultrastructural features. 
  • Hormone receptor complexes and their modulation of membrane function. 
  • Hostility and fasting glucose in African American women. 
  • Hostility, race, and glucose metabolism in nondiabetic individuals. 
  • How are we going to understand (dys)regulation of glucose metabolism? 
  • Human aging is associated with altered TNF-alpha production during hyperglycemia and hyperinsulinemia. 
  • Hydrolysis by somatic angiotensin-I converting enzyme of basic dipeptides from a cholecystokinin/gastrin and a LH-RH peptide extended at the C-terminus with gly-Arg/Lys-arg, but not from diarginyl insulin. 
  • Hyperacidity and hypergastrinemia following extensive intestinal resection. 
  • Hyperandrogenemia in human immunodeficiency virus-infected women with the lipodystrophy syndrome. 
  • Hyperglycaemia associated with lactic acidaemia in a renal allograft recipient with type I glycogen storage disease. 
  • Hyperglycemia induces insulin resistance on angiotensinogen gene expression in diabetic rat kidney proximal tubular cells. 
  • Hyperinsulinemia in the pregnant C57BL/6J mouse. 
  • Hyperkalemia: treatment options. 
  • Hypertension in CB57BL/6J mouse model of non-insulin-dependent diabetes mellitus. 
  • Hypoglycemia Communication in Primary Care Visits for Patients with Diabetes. 
  • Hypothalamic CaMKK2 contributes to the regulation of energy balance. 
  • Hypothalamic and pituitary function in hypogonadotropic hypogonadism. 
  • INSPstI polymorphism and prostate cancer in African-American men. 
  • ISPAD Guidelines. Managing diabetes in preschool children. 
  • Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus. 
  • Identification of 80K-H as a protein involved in GLUT4 vesicle trafficking. 
  • Identification of late larval stage developmental checkpoints in Caenorhabditis elegans regulated by insulin/IGF and steroid hormone signaling pathways. 
  • Identification of phosphorylation sites in the translational regulator, PHAS-I, that are controlled by insulin and rapamycin in rat adipocytes. 
  • Ildr1 gene deletion protects against diet-induced obesity and hyperglycemia. 
  • Impact of Chronic Sleep Disturbance for People Living With T1 Diabetes. 
  • Impact of Standardized Simulated Patients on First-Year Pharmacy Students' Knowledge Retention of Insulin Injection Technique and Counseling Skills. 
  • Impact of activated vitamin D on insulin resistance in nondiabetic chronic kidney disease patients. 
  • Impact of baseline insulin regimen on glycemic response to a group medical clinic intervention. 
  • Impact of donor factors and preservation on function and survival after liver transplantation. 
  • Impact of hormone replacement therapy on exercise training-induced improvements in insulin action in sedentary overweight adults. 
  • Impact of insulin reduction on glycemic control in children attending a residential diabetes camp. 
  • Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose. 
  • Impaired beta-cell sensitivity to glucose and maximal insulin secretory capacity in adolescents with type 2 diabetes. 
  • Impaired insulin response after oral but not intravenous glucose in heart- and liver-transplant recipients. 
  • Impaired insulin secretion and enhanced insulin sensitivity in cholecystokinin-deficient mice. 
  • Impaired proinsulin processing is a characteristic of transplanted islets. 
  • Impaired second phase insulin response of diabetes-prone C57BL/6J mouse islets. 
  • Implementation of a new intravenous insulin method on intermediate-care units in hospitalized patients. 
  • Importance of perioperative glycemic control in general surgery: a report from the Surgical Care and Outcomes Assessment Program. 
  • Improved glycemic control enhances the incretin effect in patients with type 2 diabetes. 
  • Improved insulin sensitivity after gastric bypass correlates with decreased total body fat, but not with changes in free fatty acids. 
  • Inaccurate Estimates of Negotiated Reimbursement Prices for Insulin-Reply. 
  • Increase in PDX-1 levels suppresses insulin gene expression in RIN 1046-38 cells. 
  • Increased Ia-antigen-bearing T cells in type I diabetes mellitus. 
  • Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype. 
  • Increased circulating Ia-antigen-bearing T cells in type I diabetes mellitus. 
  • Increased dietary fat attenuates the anorexic effects of intracerebroventricular injections of MTII. 
  • Increased insulin sensitivity in mice lacking collectrin, a downstream target of HNF-1alpha. 
  • Increased lipid accumulation and insulin resistance in transgenic mice expressing DGAT2 in glycolytic (type II) muscle. 
  • Increases in stimulated secretion of proinflammatory cytokines by blood monocytes following arousal of negative affect: the role of insulin resistance as moderator. 
  • Increasing fructose 2,6-bisphosphate overcomes hepatic insulin resistance of type 2 diabetes. 
  • Induction of autocrine epidermal growth factor receptor ligands in human keratinocytes by insulin/insulin-like growth factor-1. 
  • Induction of miR-132 and miR-212 Expression by Glucagon-Like Peptide 1 (GLP-1) in Rodent and Human Pancreatic β-Cells. 
  • Influence of fasting on carbohydrate and fat metabolism during rest and exercise in men. 
  • Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice. 
  • Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. 
  • Inhibition of Na+/H+ exchange stimulates CCK secretion in STC-1 cells. 
  • Inhibition of basal and meal-stimulated choleresis by somatostatin. 
  • Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption. 
  • Initial injectable therapy in type 2 diabetes: Key considerations when choosing between glucagon-like peptide 1 receptor agonists and insulin. 
  • Ins-4 and daf-28 function redundantly to regulate C. elegans L1 arrest. 
  • Insulin Detemir Is Transported From Blood to Cerebrospinal Fluid and Has Prolonged Central Anorectic Action Relative to NPH Insulin. 
  • Insulin Growth Factor Phenotypes in Heart Failure With Preserved Ejection Fraction, an INSPIRE Registry and CATHGEN Study. 
  • Insulin Sensitivity and β-Cell Function Improve after Gastric Bypass in Severely Obese Adolescents. 
  • Insulin Therapy and Stroke Risk in Patients With Diabetes and Atrial Fibrillation: Guilty by Association? 
  • Insulin Use and Clinical Outcomes in Patients Undergoing Coronary Artery Bypass Graft Surgery. 
  • Insulin action, type 2 diabetes, and branched-chain amino acids: A two-way street. 
  • Insulin activates a novel adipocyte mitogen-activated protein kinase kinase kinase that shows rapid phasic kinetics and is distinct from c-Raf. 
  • Insulin and diabetes cause reciprocal changes in the association of eIF-4E and PHAS-I in rat skeletal muscle. 
  • Insulin and glucagon choleresis during normoglycemia. 
  • Insulin and glucosamine infusions increase O-linked N-acetyl-glucosamine in skeletal muscle proteins in vivo. 
  • Insulin and glucose homeostasis in childhood cancer survivors treated with abdominal radiation: A pilot study. 
  • Insulin and insulin-like growth factor-1 increased in preterm neonates following massage therapy. 
  • Insulin and longevity: antidiabetic biguanides as geroprotectors. 
  • Insulin and phorbol ester stimulate phosphorylation of acetyl-CoA carboxylase at similar sites in isolated adipocytes. Lack of correspondence with sites phosphorylated on the purified enzyme by protein kinase C. 
  • Insulin can make diabetes worse: the smoldering Somogyi effect. 
  • Insulin in aging and cancer: antidiabetic drug Diabenol as geroprotector and anticarcinogen. 
  • Insulin increases central apolipoprotein E levels as revealed by an improved technique for collection of cerebrospinal fluid from rats. 
  • Insulin inhibits angiotensinogen gene expression via the mitogen-activated protein kinase pathway in rat kidney proximal tubular cells. 
  • Insulin inhibits dexamethasone effect on angiotensinogen gene expression and induction of hypertrophy in rat kidney proximal tubular cells in high glucose. 
  • Insulin or glucagon choleresis in the isolated perfused guinea pig liver. 
  • Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. 
  • Insulin receptor of fat cells in insulin-resistant metabolic states. 
  • Insulin replacement therapy in diabetic rats using an osmotic pump normalizes expression of enzymes key to hepatic carbohydrate metabolism. 
  • Insulin resistance and altered systemic glucose metabolism in mice lacking Nur77. 
  • Insulin resistance independently predicts the progression of coronary artery calcification. 
  • Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men. 
  • Insulin resistance is associated with elevated serum pigment epithelium-derived factor (PEDF) levels in morbidly obese patients. 
  • Insulin resistance syndrome and cardiovascular disease: genetics and connections to skeletal muscle function. 
  • Insulin reverses the high-fat diet-induced increase in brain Aβ and improves memory in an animal model of Alzheimer disease. 
  • Insulin therapy for ketolactic acidosis complicating malignancy. 
  • Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction. 
  • Insulin, Hyperglycemia, and Severe Retinopathy of Prematurity in Extremely Low-Birth-Weight Infants. 
  • Insulin-like signalling to the maternal germline controls progeny response to osmotic stress. 
  • Insulin-stimulated cardiac glucose oxidation is increased in high-fat diet-induced obese mice lacking malonyl CoA decarboxylase. 
  • Insulin-triggered repositioning of munc18c on syntaxin-4 in GLUT4 signalling. 
  • Insulin/IGF Signaling and Vitellogenin Provisioning Mediate Intergenerational Adaptation to Nutrient Stress. 
  • Insulin/IGF-dependent Wnt signaling promotes formation of germline tumors and other developmental abnormalities following early-life starvation in Caenorhabditis elegans. 
  • Intensive insulin therapy and mortality in critically ill patients. 
  • Intensive insulin therapy in the neurocritical care setting is associated with poor clinical outcomes. 
  • Interaction of GLP-1 and Ghrelin on Glucose Tolerance in Healthy Humans. 
  • Interactions of dietary whole-grain intake with fasting glucose- and insulin-related genetic loci in individuals of European descent: a meta-analysis of 14 cohort studies. 
  • Interventions for Diabetic Retinopathy in Type 1 Diabetes: Systematic Review and Meta-Analysis. 
  • Intestinal transplantation: the University of Wisconsin experience. 
  • Intra-Target Microdosing - A Novel Drug Development Approach: Proof of Concept, Safety, and Feasibility Study in Humans. 
  • Intraarterial Microdosing: A Novel Drug Development Approach, Proof-of-Concept PET Study in Rats. 
  • Intracellular lipid metabolism impairs β cell compensation during diet-induced obesity. 
  • Intracellular mediators of insulin action. 
  • Intracerebroventricular infusion of bombesin modulates GIP secretion in conscious dogs. 
  • Intracerebroventricular neuropeptide Y increases gastric and pancreatic secretion in the dog. 
  • Intrahepatic glucose: a requirement for neonatal ODC induction by specific hormones. 
  • Intraislet Ghrelin Signaling Does Not Regulate Insulin Secretion From Adult Mice. 
  • Intraoperative hyperglycemia and cognitive decline after CABG. 
  • Intraventricular CCK-8 reduces single meal size in the baboon by interaction with type-A CCK receptors. 
  • Investigation of the mechanisms contributing to the compensatory increase in insulin secretion during dexamethasone-induced insulin resistance in rhesus macaques. 
  • Involvement of a mitochondrial phosphatase in the regulation of ATP production and insulin secretion in pancreatic beta cells. 
  • Ionic basis of phenytoin sodium inhibition of insulin secretion in pancreatic islets. 
  • Is GLP-1 a hormone: Whether and When? 
  • Is Mid-trimester Insulin Resistance Predictive of Subsequent Puerperal Infection? A Secondary Analysis of Randomized Trial Data. 
  • Is iatrogenic sleep disturbance worth the effort in Type 1 diabetes? 
  • Is there a glycemic threshold for impaired autonomic control? 
  • Is there a role for a low-carbohydrate ketogenic diet in the management of prostate cancer? 
  • Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. 
  • Islet cell transplantation for the treatment of diabetes mellitus. 
  • Islet α cells and glucagon--critical regulators of energy homeostasis. 
  • Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional β cells. 
  • Isolated hormone receptors: physiologic and clinical implications. 
  • Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. 
  • Knock-down of LAR protein tyrosine phosphatase induces insulin resistance. 
  • Kv2.1 Clustering Contributes to Insulin Exocytosis and Rescues Human β-Cell Dysfunction. 
  • L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. 
  • L-glutamine supplementation of a high fat diet reduces body weight and attenuates hyperglycemia and hyperinsulinemia in C57BL/6J mice. 
  • Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. 
  • Leptin directly alters lipid partitioning in skeletal muscle. 
  • Leptin opposes insulin's effects on fatty acid partitioning in muscles isolated from obese ob/ob mice. 
  • Leptin therapy in insulin-deficient type I diabetes. 
  • Letter: Insulin activity: the solid matrix. 
  • Leveraging leptin for type I diabetes? 
  • Lipid partitioning, incomplete fatty acid oxidation, and insulin signal transduction in primary human muscle cells: effects of severe obesity, fatty acid incubation, and fatty acid translocase/CD36 overexpression. 
  • Lipid-induced mitochondrial stress and insulin action in muscle. 
  • Lipopolysaccharide Potentiates Insulin-Driven Hypoglycemic Shock. 
  • Long-chain omega-3 fatty acids regulate bovine whole-body protein metabolism by promoting muscle insulin signalling to the Akt-mTOR-S6K1 pathway and insulin sensitivity. 
  • Long-lived implanted silastic drum glucose sensors. 
  • Long-term effects of a high-carbohydrate diet and exercise on insulin action in older subjects with impaired glucose tolerance. 
  • Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. 
  • Longitudinal multi-omics of host-microbe dynamics in prediabetes. 
  • Loss of sirtuin 4 leads to elevated glucose- and leucine-stimulated insulin levels and accelerated age-induced insulin resistance in multiple murine genetic backgrounds. 
  • Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility. 
  • Lower brain-derived neurotrophic factor in patients with prader-willi syndrome compared to obese and lean control subjects. 
  • Management of Preexisting Diabetes in Pregnancy: A Review. 
  • Management of Type 1 Diabetes With a Very Low-Carbohydrate Diet. 
  • Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). 
  • Manipulation of insulin signaling phenocopies evolution of a host-associated polyphenism. 
  • Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study. 
  • Maternal transfer of environmentally relevant polybrominated diphenyl ethers (PBDEs) produces a diabetic phenotype and disrupts glucoregulatory hormones and hepatic endocannabinoids in adult mouse female offspring. 
  • Maturation of the adrenal medulla. II. Content and properties of catecholamine storage vesicles of the rat. 
  • Meal feeding improves oral glucose tolerance in male rats and causes adaptations in postprandial islet hormone secretion that are independent of plasma incretins or glycemia. 
  • Meal-anticipatory glucagon-like peptide-1 secretion in rats. 
  • Mechanism of insulin gene regulation by the pancreatic transcription factor Pdx-1: application of pre-mRNA analysis and chromatin immunoprecipitation to assess formation of functional transcriptional complexes. 
  • Mechanism of insulin incorporation into alpha 2-macroglobulin: implications for the study of peptide and growth factor binding. 
  • Mechanism of postgastrectomy hypoglycemia. 
  • Mechanisms by which smoothelin-like protein 1 reverses insulin resistance in myotubules and mice. 
  • Mechanisms of disease:Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. 
  • Mechanisms of surgical control of type 2 diabetes: GLP-1 is the key factor-Maybe. 
  • Membrane receptors as general markers for plasma membrane isolation procedures. The use of 125-I-labeled wheat germ agglutinin, insulin, and cholera toxin. 
  • Meta-analysis investigating associations between healthy diet and fasting glucose and insulin levels and modification by loci associated with glucose homeostasis in data from 15 cohorts. 
  • Meta-analysis of gene-environment interaction: joint estimation of SNP and SNP × environment regression coefficients. 
  • Metabolic Dysregulation in Hepacivirus Infection of Common Marmosets (Callithrix jacchus). 
  • Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. 
  • Metabolic coupling factors in pancreatic beta-cell signal transduction. 
  • Metabolic cycling in control of glucose-stimulated insulin secretion. 
  • Metabolic effects and efficacy of a triphasic oral contraceptive (norgestimate/ethinyl estradiol). 
  • Metabolic effects of dietary lactose in adult female rats. 
  • Metabolic profiling in Prader-Willi syndrome and nonsyndromic obesity: sex differences and the role of growth hormone. 
  • Metabolic remodeling of human skeletal myocytes by cocultured adipocytes depends on the lipolytic state of the system. 
  • Metabolomics applied to islet nutrient sensing mechanisms. 
  • Metabolomics reveals unexpected responses to oral glucose. 
  • Metal-Organic Framework Encapsulation Preserves the Bioactivity of Protein Therapeutics. 
  • Methylprednisolone for Heart Surgery in Infants - A Randomized, Controlled Trial. 
  • Microinjection of a 19-kDa guanine nucleotide-binding protein inhibits maturation of Xenopus oocytes. 
  • Minimal versus umbilical waist circumference measures as indicators of cardiovascular disease risk. 
  • Mitochondrial GLUT10 facilitates dehydroascorbic acid import and protects cells against oxidative stress: mechanistic insight into arterial tortuosity syndrome. 
  • Mitochondrial dysfunction and insulin resistance: a matter of lifestyle? 
  • Mitochondrial metabolism sets the maximal limit of fuel-stimulated insulin secretion in a model pancreatic beta cell: a survey of four fuel secretagogues. 
  • Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes. 
  • Modulation of pancreatic exocrine and endocrine secretion. 
  • Molecular engineering of the pancreatic beta-cell. 
  • Molecular or pharmacologic perturbation of the link between glucose and lipid metabolism is without effect on glucose-stimulated insulin secretion. A re-evaluation of the long-chain acyl-CoA hypothesis. 
  • Momentary Predictors of Insulin Restriction Among Adults With Type 1 Diabetes and Eating Disorder Symptomatology. 
  • Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study. 
  • Multiple mechanisms control phosphorylation of PHAS-I in five (S/T)P sites that govern translational repression. 
  • Muscarinic stimulation and antagonism and glucoregulation in nondiabetic and obese hyperglycemic mice. 
  • Muscle atrophy in transgenic mice expressing a human TSC1 transgene. 
  • Muscle glycogen content and glucose uptake during exercise in humans: influence of prior exercise and dietary manipulation. 
  • Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility. 
  • Mutational analysis of the coding regions of the genes encoding protein kinase B-alpha and -beta, phosphoinositide-dependent protein kinase-1, phosphatase targeting to glycogen, protein phosphatase inhibitor-1, and glycogenin: lessons from a search for genetic variability of the insulin-stimulated glycogen synthesis pathway of skeletal muscle in NIDDM patients. 
  • Need for insulin therapy in type II diabetes mellitus. A randomized trial. 
  • Nephrogenic diabetes insipidus with new onset diabetic ketoacidosis in a child - challenges in fluid and electrolyte management. 
  • Neural ensemble coding of satiety states. 
  • Neurogenic differentiation of murine and human adipose-derived stromal cells. 
  • Neurohormonal regulation of pancreatic secretion. 
  • Neurohormonal signaling via a sulfotransferase antagonizes insulin-like signaling to regulate a Caenorhabditis elegans stress response. 
  • Neurotrophin Signaling Is Required for Glucose-Induced Insulin Secretion. 
  • New genetic loci link adipose and insulin biology to body fat distribution. 
  • New lessons in the regulation of glucose metabolism taught by the glucose 6-phosphatase system. 
  • New ways in which GLP-1 can regulate glucose homeostasis. 
  • Nitrogen-sparing intravenous fluids in postperative patients. 
  • Nitrosative modifications of protein and lipid signaling molecules by reactive nitrogen species. 
  • Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome. 
  • Nondialytic management of hyperkalemia and pulmonary edema among end-stage renal disease patients: an evaluation of the evidence. 
  • Nonobese diabetic congenic strain analysis of autoimmune diabetes reveals genetic complexity of the Idd18 locus and identifies Vav3 as a candidate gene. 
  • Nonproteolytic incorporation of protein ligands into human alpha 2-macroglobulin: implications for the binding mechanism of alpha 2-macroglobulin. 
  • Normal flux through ATP-citrate lyase or fatty acid synthase is not required for glucose-stimulated insulin secretion. 
  • Novel insulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expression. 
  • Nuclear factor erythroid-derived factor 2-related factor 2 regulates transcription of CCAAT/enhancer-binding protein β during adipogenesis. 
  • Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. 
  • Nutrition for the diabetic pregnant woman. 
  • Okadaic acid mimics the action of insulin in stimulating protein kinase activity in isolated adipocytes. The role of protein phosphatase 2a in attenuation of the signal. 
  • Olanzapine, new-onset diabetes mellitus, and risk for insulin overdose. 
  • One-year results from the first US-based enhanced recovery after cardiac surgery (ERAS Cardiac) program. 
  • Ontogenesis of prolactin receptors in the human fetus: roles in fetal development. 
  • Ontogeny of adrenomedullary responses to hypoxia and hypoglycemia: role of splanchnic innervation. 
  • Open Source Closed-Loop Insulin Delivery Systems: A Clash of Cultures or Merging of Diverse Approaches? 
  • Optimizing hospital use of intravenous insulin therapy: improved management of hyperglycemia and error reduction with a new nomogram. 
  • Optimizing perioperative glycemic control. 
  • Oral L-arginine stimulates GLP-1 secretion to improve glucose tolerance in male mice. 
  • Overexpression of G11alpha and isoforms of phospholipase C in islet beta-cells reveals a lack of correlation between inositol phosphate accumulation and insulin secretion. 
  • Overexpression of a modified human malonyl-CoA decarboxylase blocks the glucose-induced increase in malonyl-CoA level but has no impact on insulin secretion in INS-1-derived (832/13) beta-cells. 
  • Overexpression of bone morphogenetic protein 10 in myocardium disrupts cardiac postnatal hypertrophic growth. 
  • Overexpression of hexokinase I in isolated islets of Langerhans via recombinant adenovirus. Enhancement of glucose metabolism and insulin secretion at basal but not stimulatory glucose levels. 
  • Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion. 
  • Overexpression of protein targeting to glycogen (PTG) in rat hepatocytes causes profound activation of glycogen synthesis independent of normal hormone- and substrate-mediated regulatory mechanisms. 
  • Ovine placental lactogen inhibits glucagon-induced glycogenolysis in fetal rat hepatocytes. 
  • Ovine placental lactogen, but not growth hormone, stimulates amino acid transport in fetal rat diaphragm. 
  • Oxidative and nonoxidative macronutrient disposal in lean and obese men after mixed meals. 
  • PHAS proteins as mediators of the actions of insulin, growth factors and cAMP on protein synthesis and cell proliferation. 
  • PHAS-I as a link between mitogen-activated protein kinase and translation initiation. 
  • PLG scaffold delivered antigen-specific regulatory T cells induce systemic tolerance in autoimmune diabetes. 
  • Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. 
  • Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse. 
  • Pancreatic hormone response to neuropeptide Y (NPY) perifusion in vitro. 
  • Pancreatic islet cell therapy for type I diabetes: understanding the effects of glucose stimulation on islets in order to produce better islets for transplantation. 
  • Pancreatic islets and insulinoma cells express a novel isoform of group VIA phospholipase A2 (iPLA2 beta) that participates in glucose-stimulated insulin secretion and is not produced by alternate splicing of the iPLA2 beta transcript. 
  • Parents' experiences of managing their child's diabetes using an insulin pump: a qualitative study. 
  • Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1. 
  • Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading. 
  • Patient Self-Management of Diabetes Care in the Inpatient Setting: Pro. 
  • Patient time costs associated with sensor-augmented insulin pump therapy for type 1 diabetes: results from the STAR 3 randomized trial. 
  • Perceptions and experiences of using automated bolus advisors amongst people with type 1 diabetes: a longitudinal qualitative investigation. 
  • Performance of an Electronic Decision Support System as a Therapeutic Intervention During a Multicenter PICU Clinical Trial: Heart and Lung Failure-Pediatric Insulin Titration Trial (HALF-PINT). 
  • Peripheral metabolic actions of leptin. 
  • Perivascular mesenchymal cells control adipose-tissue macrophage accrual in obesity. 
  • Peroxisome Proliferator-Activated Receptor γ and Its Role in Adipocyte Homeostasis and Thiazolidinedione-Mediated Insulin Sensitization. 
  • Persistent oxidative stress due to absence of uncoupling protein 2 associated with impaired pancreatic beta-cell function. 
  • Pharmacologic Treatment of Diabetes in Pregnancy. 
  • Pharmacological targeting of the mitochondrial phosphatase PTPMT1. 
  • Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes. 
  • Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug. 
  • Phenotypic Characterization of MIP-CreERT1Lphi Mice With Transgene-Driven Islet Expression of Human Growth Hormone. 
  • Phenotypic characterization of Bbs4 null mice reveals age-dependent penetrance and variable expressivity. 
  • Phosphatase and tensin homolog (PTEN) regulates hepatic lipogenesis, microsomal triglyceride transfer protein, and the secretion of apolipoprotein B-containing lipoproteins. 
  • Phosphoproteomic mapping reveals distinct signaling actions and activation of muscle protein synthesis by Isthmin-1. 
  • Phosphorylation of PHAS-I by mitogen-activated protein (MAP) kinase. Identification of a site phosphorylated by MAP kinase in vitro and in response to insulin in rat adipocytes. 
  • Physical activity and NIDDM in African-Americans. The Pitt County Study. 
  • Physiologic concentrations of exogenously infused ghrelin reduces insulin secretion without affecting insulin sensitivity in healthy humans. 
  • Physiological concentrations of cholecystokinin stimulate amino acid-induced insulin release in humans. 
  • Physiological receptors as physicochemical entities. 
  • Physiological role for cholecystokinin in reducing postprandial hyperglycemia in humans. 
  • Pigment epithelium-derived factor (PEDF) suppresses IL-1β-mediated c-Jun N-terminal kinase (JNK) activation to improve hepatocyte insulin signaling. 
  • Placental hormones and the control of maternal metabolism and fetal growth. 
  • Plasma acylcarnitine profiling indicates increased fatty acid oxidation relative to tricarboxylic acid cycle capacity in young, healthy low birth weight men. 
  • Plasma acylcarnitines during insulin stimulation in humans are reflective of age-related metabolic dysfunction. 
  • Plasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patients. 
  • Plasma glucose response to recreational diving in novice teenage divers with insulin-requiring diabetes mellitus. 
  • Plexin D1 determines body fat distribution by regulating the type V collagen microenvironment in visceral adipose tissue. 
  • Polycystic ovary syndrome and severe nonalcoholic steatohepatitis: beneficial effect of modest weight loss and exercise on liver biopsy findings. 
  • Polyvinyl Pyrrolidone: A Novel Cryoprotectant in Islet Cell Cryopreservation. 
  • Positive Impact of Continuous-Flow Left Ventricular Assist Device Implantation on Glycemic Control in Patients with Type 2 Diabetes Mellitus and Advanced Chronic Systolic Heart Failure. 
  • Postoperative hyperglycemia after 4- vs 8-10-mg dexamethasone for postoperative nausea and vomiting prophylaxis in patients with type II diabetes mellitus: a retrospective database analysis. 
  • Postprandial metabolite profiles reveal differential nutrient handling after bariatric surgery compared with matched caloric restriction. 
  • Potassium and glucose measures in older adults: the Cardiovascular Health Study. 
  • Pparg-P465L mutation worsens hyperglycemia in Ins2-Akita female mice via adipose-specific insulin resistance and storage dysfunction. 
  • Pre-existing, Concurrent/Early-Onset, and Late-Onset Diabetes in Chronic Pancreatitis: Do Outcomes Differ? 
  • Precocious development of sympatho-adrenal function in rats whose mothers received methadone. 
  • Predictors of target organ damage in hypertensive blacks and whites. 
  • Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. 
  • Premature development of cardiac sympathetic neurotransmission in the fetal alcohol syndrome. 
  • Prenatal air pollution exposure induces neuroinflammation and predisposes offspring to weight gain in adulthood in a sex-specific manner. 
  • Preparation of inverted plasma membrane vesicles from isolated adipocytes. 
  • Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort. 
  • Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. 
  • Prevalences of type 2 diabetes, the insulin resistance syndrome, and coronary heart disease in an elderly, biethnic population. 
  • Procurement, preservation, and transport of cadaver kidneys. 
  • Progesterone inhibits human infragenicular arterial smooth muscle cell proliferation induced by high glucose and insulin concentrations. 
  • Prolactin induction of insulin gene expression: the roles of glucose and glucose transporter-2. 
  • Prolactin induction of insulin gene transcription: roles of glucose and signal transducer and activator of transcription 5. 
  • Prolongation of normoglycemia in patients with type I glycogen storage disease. 
  • Prospective association between fasting NEFA and type 2 diabetes: impact of post-load glucose. 
  • Protein kinase-zeta interacts with munc18c: role in GLUT4 trafficking. 
  • Protein nutrition and resistance exercise. 
  • Protein nutrition, exercise and aging. 
  • Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting. 
  • ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function. 
  • Rabbit antithymocyte globulin induction and sirolimus monotherapy supports prolonged islet allograft function in a nonhuman primate islet transplantation model. 
  • Race differences in the relation of vitamins A, C, E, and β-carotene to metabolic and inflammatory biomarkers. 
  • Randomized nutrition education intervention to improve carbohydrate counting in adolescents with type 1 diabetes study: is more intensive education needed? 
  • Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14. 
  • Rap1 promotes multiple pancreatic islet cell functions and signals through mammalian target of rapamycin complex 1 to enhance proliferation. 
  • Rapid deterioration of insulin secretion in obese adolescents preceding the onset of type 2 diabetes. 
  • Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease. 
  • Reactive oxygen species blockade and action of insulin on expression of angiotensinogen gene in proximal tubular cells. 
  • Recent advances in pancreatic endocrine and exocrine secretion. 
  • Recent advances in the regulation of pancreatic secretion. 
  • Recombinant glucagon-like peptide-1 (7-36 amide) lowers fasting serum glucose in a broad spectrum of patients with type 2 diabetes. 
  • Recovery of rat adrenal amine stores after insulin administration. 
  • Reduced postprandial cholecystokinin (CCK) secretion in patients with noninsulin-dependent diabetes mellitus: evidence for a role for CCK in regulating postprandial hyperglycemia. 
  • Regional fat distribution and metabolism in a new mouse model (C57BL/6J) of non-insulin-dependent diabetes mellitus. 
  • Regulation of Glucose Production in the Pathogenesis of Type 2 Diabetes. 
  • Regulation of Sertoli cell differentiation by the testicular paracrine factor PModS: potential role of immediate-early genes. 
  • Regulation of adrenal chromaffin cell development by the central monoaminergic system: differential control of norepinephrine and epinephrine levels and secretory responses. 
  • Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. 
  • Regulation of cerebral glucose metabolism. 
  • Regulation of expression of transcobalamin II receptor in the rat. 
  • Regulation of hepatic biliary secretion. 
  • Regulation of insulin receptors in frog erythrocytes by insulin and concanavalin A. Evidence for discrete classes of insulin binding sites. 
  • Regulation of insulin secretion from novel engineered insulinoma cell lines. 
  • Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion. 
  • Regulation of pancreatic endocrine function by cholecystokinin: studies with MK-329, a nonpeptide cholecystokinin receptor antagonist. 
  • Regulation of skeletal muscle oxidative capacity and insulin signaling by the mitochondrial rhomboid protease PARL. 
  • Relation between sulfonylurea therapy, complications, and outcome for elderly patients with acute myocardial infarction. 
  • Relation of severe coronary artery narrowing to insulin or thiazolidinedione use in patients with type 2 diabetes mellitus (from the Bypass Angioplasty Revascularization Investigation 2 Diabetes Study). 
  • Relations between deletion polymorphism of the angiotensin-converting enzyme gene and insulin resistance, glucose intolerance, hyperinsulinemia, and dyslipidemia. 
  • Relations of insulin sensitivity to longitudinal blood pressure tracking: variations with baseline age, body mass index, and blood pressure. 
  • Relationship among brain and blood glucose levels and spontaneous and glucoprivic feeding. 
  • Relationship between insulin-mediated turnover of glucosamine-labeled lipids and activity of the insulin receptor tyrosine kinase. 
  • Relationships of plasma C-peptide and gender to the urinary excretion of inositols in older people. 
  • Replication of genome-wide association signals of type 2 diabetes in Han Chinese in a prospective cohort. 
  • Repositioning Glucagon Action in the Physiology and Pharmacology of Diabetes. 
  • Research Resource: Roles for Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) in Systems Metabolism. 
  • Resistance to adenovirally induced hyperleptinemia in rats. Comparison of ventromedial hypothalamic lesions and mutated leptin receptors. 
  • Response to: 'Pharmacokinetic/pharmacodynamic properties and efficacy/safety of U-500R from randomized clinical studies'. 
  • Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in zucker diabetic fatty rats. 
  • Resveratrol worsens survival in SCID mice with prostate cancer xenografts in a cell-line specific manner, through paradoxical effects on oncogenic pathways. 
  • Reversal of diet-induced obesity and diabetes in C57BL/6J mice. 
  • Reversal of diet-induced obesity increases insulin transport into cerebrospinal fluid and restores sensitivity to the anorexic action of central insulin in male rats. 
  • Revisiting NPH Insulin for Type 2 Diabetes: Is a Step Back the Path Forward? 
  • Revisiting the connection between intramyocellular lipids and insulin resistance: a long and winding road. 
  • Risking health to avoid injections: preferences of Canadians with type 2 diabetes. 
  • Role of transcription factor NFAT in glucose and insulin homeostasis. 
  • Role of vagal activation in postprandial glucose metabolism after gastric bypass in individuals with and without hypoglycaemia. 
  • Roles of inositol phosphates and inositol pyrophosphates in development, cell signaling and nuclear processes. 
  • Roles of the lactogens and somatogens in perinatal and postnatal metabolism and growth: studies of a novel mouse model combining lactogen resistance and growth hormone deficiency. 
  • SIRT3 Directs Carbon Traffic in Muscle to Promote Glucose Control. 
  • SIRT4 Is a Lysine Deacylase that Controls Leucine Metabolism and Insulin Secretion. 
  • SMPDL3b modulates insulin receptor signaling in diabetic kidney disease. 
  • Safe and Efficacious Use of Automated Bolus Advisors in Individuals Treated With Multiple Daily Insulin Injection (MDI) Therapy: Lessons Learned From the Automated Bolus Advisor Control and Usability Study (ABACUS). 
  • Safely Converting an Entire Academic Medical Center From Sliding Scale to Basal Bolus Insulin via Implementation of the eGlycemic Management System. 
  • Selection of insulinoma cell lines with resistance to interleukin-1beta- and gamma-interferon-induced cytotoxicity. 
  • Selective upregulated expression of the alpha2-macroglobulin signaling receptor in highly metastatic 1-LN prostate carcinoma cells. 
  • Selenium Augments microRNA Directed Reprogramming of Fibroblasts to Cardiomyocytes via Nanog. 
  • Self-management practices of Chinese Americans with type 2 diabetes. 
  • Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for gender disparity. 
  • Sensitive and precise quantification of insulin-like mRNA expression in Caenorhabditis elegans. 
  • Sequential Multiple Assignment Randomized Trial (SMART) to identify optimal sequences of telemedicine interventions for improving initiation of insulin therapy: A simulation study. 
  • Serum and dietary potassium and risk of incident type 2 diabetes mellitus: The Atherosclerosis Risk in Communities (ARIC) study. 
  • Serum insulin levels and the prevalence of adenomatous and hyperplastic polyps in the proximal colon. 
  • Severe insulin resistance in a patient with type 1 diabetes and stiff-man syndrome treated with insulin lispro. 
  • Sex differences in the amount of insulin extractable from diabetic human pancreas. 
  • Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability. 
  • Silencing of cytosolic or mitochondrial isoforms of malic enzyme has no effect on glucose-stimulated insulin secretion from rodent islets. 
  • Similar effects of roux-en-Y gastric bypass and vertical sleeve gastrectomy on glucose regulation in rats. 
  • Simplifying therapy to assure glycemic control and engagement (STAGE) in poorly-controlled diabetes: A pilot study. 
  • Single Cell Chemical Cytometry of Akt Activity in Rheumatoid Arthritis and Normal Fibroblast-like Synoviocytes in Response to Tumor Necrosis Factor α. 
  • Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial. 
  • Skeletal muscle protein synthesis and the abundance of the mRNA translation initiation repressor PDCD4 are inversely regulated by fasting and refeeding in rats. 
  • Skeletal muscle-specific Cre recombinase expression, controlled by the human α-skeletal actin promoter, improves glucose tolerance in mice fed a high-fat diet. 
  • Sleeve gastrectomy rapidly enhances islet function independently of body weight. 
  • Standardization of the single-breath diffusing capacity in a multicenter clinical trial. 
  • Stimulation of brain hexokinase gene expression by recombinant brain insulin-like growth factor in C6 glial cells. 
  • Stimulation of human and rat islet beta-cell proliferation with retention of function by the homeodomain transcription factor Nkx6.1. 
  • Stimulation of insulin secretion by a rapid intravenous calcium infusion in patients with beta-cell neoplasms of the pancreas. 
  • Stimulus/secretion coupling factors in glucose-stimulated insulin secretion: insights gained from a multidisciplinary approach. 
  • Strain-specific response to beta 3-adrenergic receptor agonist treatment of diet-induced obesity in mice. 
  • Stress and autonomic nervous system in type II diabetes. A hypothesis. 
  • Sugar-sweetened beverage intake associations with fasting glucose and insulin concentrations are not modified by selected genetic variants in a ChREBP-FGF21 pathway: a meta-analysis. 
  • Suitability of capillary blood glucose analysis in patients receiving vasopressors. 
  • Suppression of beta cell energy metabolism and insulin release by PGC-1alpha. 
  • Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect. 
  • Suppressive Effects of Insulin on Tumor Necrosis Factor-Dependent Early Osteoarthritic Changes Associated With Obesity and Type 2 Diabetes Mellitus. 
  • Survival of allografted pancreatic islets in the subretinal space in rats. 
  • Survival of subretinal pancreatic islet cell allografts and apoptosis in infiltrating lymphocytes in rats. 
  • Sympatho-adrenal development in perinatally addicted rats. 
  • Synergistic effect of insulin and follicle-stimulating hormone on biochemical and morphological differentiation of porcine granulosa cells in vitro. 
  • Synergistic effects of oPL and insulin on glycogen metabolism in fetal rat hepatocytes. 
  • Systematic literature review: quality of life associated with insulin pump use in Type 1 diabetes. 
  • Systematic review and meta-analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors. 
  • Systemic administration of HVJ viral coat-liposome complex containing human insulin vector decreases glucose level in diabetic mouse: A model of gene therapy. 
  • TCF1 links GIPR signaling to the control of beta cell function and survival. 
  • Taking aim at islet hormones with GLP-1: is insulin or glucagon the better target? 
  • Tamoxifen Improves Glucose Tolerance in a Delivery-, Sex-, and Strain-Dependent Manner in Mice. 
  • Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance. 
  • Targeted overexpression of an inactive calmodulin that binds Ca2+ to the mouse pancreatic beta-cell results in impaired secretion and chronic hyperglycemia. 
  • Targeting BCAA Catabolism to Treat Obesity-Associated Insulin Resistance. 
  • Technical problems with agarose-hormone linkage. 
  • Technosphere insulin: inhaled prandial insulin. 
  • Temperature-sensitive hydrogels with SiO2-Au nanoshells for controlled drug delivery. 
  • Tempol therapy attenuates medial smooth muscle cell apoptosis and neointima formation after balloon catheter injury in carotid artery of diabetic rats. 
  • Temporal plasticity of insulin and incretin secretion and insulin sensitivity following sleeve gastrectomy contribute to sustained improvements in glucose control. 
  • Testing a very low-carbohydrate adaption of the Diabetes Prevention Program among adults with prediabetes: study protocol for the Lifestyle Education about prediabetes (LEAP) trial. 
  • Tetrahydroindenoindole inhibits the progression of diabetes in mice. 
  • The 1p13.3 LDL (C)-associated locus shows large effect sizes in young populations. 
  • The 24-hour average concentration of cortisol is elevated in obese African-American youth with type 2 diabetes. 
  • The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome. 
  • The Effect of Vigorous- Versus Moderate-Intensity Aerobic Exercise on Insulin Action. 
  • The Enigma of Glucose and Lipid Metabolism. 
  • The FGF21 response to fructose predicts metabolic health and persists after bariatric surgery in obese humans. 
  • The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. II. An autosomal genome scan for diabetes-related quantitative-trait loci. 
  • The HMG-CoA reductase inhibitor pravastatin stimulates insulin secretion through organic anion transporter polypeptides. 
  • The Limited Role of Glucagon for Ketogenesis During Fasting or in Response to SGLT2 Inhibition. 
  • The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion. 
  • The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy. 
  • The Nkx6.1 homeodomain transcription factor suppresses glucagon expression and regulates glucose-stimulated insulin secretion in islet beta cells. 
  • The Prohormone VGF Regulates β Cell Function via Insulin Secretory Granule Biogenesis. 
  • The Relation of Light-to-Moderate Alcohol Consumption to Glucose Metabolism and Insulin Resistance in Nondiabetic Adults: the Moderating Effects of Depressive Symptom Severity, Adiposity, and Sex. 
  • The Relative Effectiveness of Pumps Over MDI and Structured Education (REPOSE): study protocol for a cluster randomised controlled trial. 
  • The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis. 
  • The W64R variant of the beta3-adrenergic receptor is not associated with type II diabetes or obesity in a large Finnish sample. 
  • The beta-adrenergic receptor. 
  • The carbohydrate-insulin model: a physiological perspective on the obesity pandemic. 
  • The constitutive secretory pathway is a major route for islet amyloid polypeptide secretion in neonatal but not adult rat islet cells. 
  • The contribution of enteroinsular hormones to the pathogenesis of type 2 diabetes mellitus. 
  • The control of body size in insects. 
  • The control of growth. 
  • The developmental control of size in insects. 
  • The distinct roles of insulin signaling in polyphenic development. 
  • The effect of abdominal evisceration or adrenalectomy on insulin choleresis. 
  • The effect of carbohydrate restriction on prostate cancer tumor growth in a castrate mouse xenograft model. 
  • The effect of chronic twice daily exenatide treatment on β-cell function in new onset type 2 diabetes. 
  • The effect of duodenal-jejunal bypass on glucose-dependent insulinotropic polypeptide secretion in Wistar rats. 
  • The effect of intraocular irrigating solutions on lens clarity in normal and diabetic rabbits. 
  • The effect of membrane filtration upon protein conformation. 
  • The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglucose and nitrogen-13-ammonia in normal volunteers. 
  • The effect of octreotide on hepatic regeneration in rats. 
  • The effect of plating density on granulosa cell growth and differentiation in vitro. 
  • The effect of the PREMIER interventions on insulin sensitivity. 
  • The effects of aerobic, resistance, and combination training on insulin sensitivity and secretion in overweight adults from STRRIDE AT/RT: a randomized trial. 
  • The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. 
  • The effects of relaxations on glucose tolerance in non-insulin-dependent diabetes. 
  • The effects of varying dietary carbohydrate and fat content on survival in a murine LNCaP prostate cancer xenograft model. 
  • The enteroinsular axis revisited. A novel role for an incretin. 
  • The hepatic extraction of gastric inhibitory polypeptide and insulin. 
  • The impact of exercise training compared to caloric restriction on hepatic and peripheral insulin resistance in obesity. 
  • The incretin effect in obese adolescents with and without type 2 diabetes: impaired or intact? 
  • The incretins and beta-cell health: contrasting glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 as a path to understand islet function in diabetes. 
  • The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. 
  • The insulinomimetic effects of the polar head group of an insulin-sensitive glycophospholipid on pyruvate dehydrogenase in both subcellular and whole cell assays. 
  • The interplay of prolactin and the glucocorticoids in the regulation of beta-cell gene expression, fatty acid oxidation, and glucose-stimulated insulin secretion: implications for carbohydrate metabolism in pregnancy. 
  • The intravenous insulin tolerance test in type I diabetes. 
  • The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index. 
  • The mitochondrial 2-oxoglutarate carrier is part of a metabolic pathway that mediates glucose- and glutamine-stimulated insulin secretion. 
  • The mitochondrial citrate/isocitrate carrier plays a regulatory role in glucose-stimulated insulin secretion. 
  • The past, present, and future physiology and pharmacology of glucagon. 
  • The pathogenesis of insulin resistance in children: metabolic complications and the roles of diet, exercise and pharmacotherapy in the prevention of type 2 diabetes. 
  • The pathway mediating insulin's effects on pyruvate dehydrogenase bypasses the insulin receptor tyrosine kinase. 
  • The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin. 
  • The placental lactogen receptor in maternal and fetal sheep liver: regulation by glucose and role in the pathogenesis of fasting during pregnancy. 
  • The predictive value of donor liver biopsies on the development of primary nonfunction after orthotopic liver transplantation. 
  • The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance. 
  • The relationship of insulin secretion and GAD65 antibody levels at diagnosis on glycemic control in type 2 diabetes. 
  • The repression of hormone-activated PEPCK gene expression by glucose is insulin-independent but requires glucose metabolism. 
  • The role of AMPK and mTOR in nutrient sensing in pancreatic beta-cells. 
  • The role of energy expenditure in the differential weight loss in obese women on low-fat and low-carbohydrate diets. 
  • The role of motor activity in diet-induced obesity in C57BL/6J mice. 
  • The role of protein kinase C in laminin-mediated neurite outgrowth. 
  • The role of the transcription factor ETV5 in insulin exocytosis. 
  • The role of voltage-gated potassium channels Kv2.1 and Kv2.2 in the regulation of insulin and somatostatin release from pancreatic islets. 
  • The role of β cell glucagon-like peptide-1 signaling in glucose regulation and response to diabetes drugs. 
  • The use of UW solution in clinical transplantation. A 4-year experience. 
  • Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray. 
  • Time of Day When Type 1 Diabetes Patients With Eating Disorder Symptoms Most Commonly Restrict Insulin. 
  • Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist. 
  • Tissue norepinephrine concentration in spontaneously diabetic Chinese hamsters. 
  • To grow or not to grow: nutritional control of development during Caenorhabditis elegans L1 arrest. 
  • Topographic separation of adenylate cyclase and hormone receptors in the plasma membrane of toad erythrocyte ghosts. 
  • Trans-ethnic Meta-analysis and Functional Annotation Illuminates the Genetic Architecture of Fasting Glucose and Insulin. 
  • Transcriptional regulation of the human alpha1a-adrenergic receptor gene. Characterization Of the 5'-regulatory and promoter region. 
  • Transdermal delivery of macromolecules by erbium:YAG laser. 
  • Transfection of AtT-20ins cells with GLUT-2 but not GLUT-1 confers glucose-stimulated insulin secretion. Relationship to glucose metabolism. 
  • Transferability and fine-mapping of glucose and insulin quantitative trait loci across populations: CARe, the Candidate Gene Association Resource. 
  • Transgenic mice overproducing islet amyloid polypeptide have increased insulin storage and secretion in vitro. 
  • Transient effects of long-term leptin supplementation in the prevention of diet-induced obesity in mice. 
  • Treatment with incretins does not increase the risk of pancreatic diseases compared to older anti-hyperglycaemic drugs, when added to metformin: real world evidence in people with Type 2 diabetes. 
  • Treatment with the 3-ketoacyl-CoA thiolase inhibitor trimetazidine does not exacerbate whole-body insulin resistance in obese mice. 
  • Trends in Insulin Out-of-Pocket Costs and Reimbursement Price Among US Patients With Private Health Insurance, 2006-2017. 
  • Triglyceride Induced Metabolic Inflammation: Potential Connection of Insulin Resistance and Recurrent Pregnancy Loss. 
  • Two insulin receptors determine alternative wing morphs in planthoppers. 
  • Type 1 Diabetes Mellitus. 
  • Type III Hypersensitivity Reaction to Subcutaneous Insulin Preparations in a Type 1 Diabetic. 
  • Ubiquitin fold modifier 1 (UFM1) and its target UFBP1 protect pancreatic beta cells from ER stress-induced apoptosis. 
  • Underexpression of beta cell high Km glucose transporters in noninsulin-dependent diabetes. 
  • Understanding of basic mechanisms of beta-cell function and survival: prelude to new diabetes therapies. 
  • Unsupervised home use of an overnight closed-loop system over 3-4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes. 
  • Up-regulation of GRP78 and antiapoptotic signaling in murine peritoneal macrophages exposed to insulin. 
  • Update on preservation of liver grafts. 
  • Use of an automated bolus calculator reduces fear of hypoglycemia and improves confidence in dosage accuracy in patients with type 1 diabetes mellitus treated with multiple daily insulin injections. 
  • Use of an insulin bolus advisor facilitates earlier and more frequent changes in insulin therapy parameters in suboptimally controlled patients with diabetes treated with multiple daily insulin injection therapy: results of the ABACUS trial. 
  • Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial. 
  • Use of automated bolus advisors may improve adherence to multiple daily insulin injection therapy. 
  • Using insulin to prevent hyperglycemia in surgical patients. 
  • Using population selection and sequencing to characterize natural variation of starvation resistance in Caenorhabditis elegans . 
  • Uterine leiomyomata in relation to insulin-like growth factor-I, insulin, and diabetes. 
  • Utility of Continuous Glucose Monitoring vs Meal Study in Detecting Hypoglycemia After Gastric Bypass. 
  • Utilization of pediatric donors for pancreas transplantation. 
  • Ventromedial hypothalamic glucokinase is an important mediator of the counterregulatory response to insulin-induced hypoglycemia. 
  • Veterans' Interpretation of Diabetes Distress in Diabetes Self-Management: Findings From Cognitive Interviews. 
  • Viral Infection "Interferes" with Glucose Tolerance. 
  • Visceral fat and adiponectin: associations with insulin resistance are tissue-specific in women. 
  • Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats. 
  • What End Users and Stakeholders Want From Automated Insulin Delivery Systems. 
  • While tinkering with the beta-cell...metabolic regulatory mechanisms and new therapeutic strategies: American Diabetes Association Lilly Lecture, 2001. 
  • Workshop IX--Lipids, insulin, diabetes. 
  • Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. 
  • [Insulin producing cells as therapy in diabetes mellitus]. 
  • beta-arrestin-1 competitively inhibits insulin-induced ubiquitination and degradation of insulin receptor substrate 1. 
  • beta-cell function in normal rats made chronically hyperleptinemic by adenovirus-leptin gene therapy. 
  • dbl-1/TGF-β and daf-12/NHR Signaling Mediate Cell-Nonautonomous Effects of daf-16/FOXO on Starvation-Induced Developmental Arrest 
  • β Cell tone is defined by proglucagon peptides through cAMP signaling. 
  • β-Cell Function Over Time in Adolescents With New Type 2 Diabetes and Obese Adolescents Without Diabetes. 
  • β-Cell Inactivation of Gpr119 Unmasks Incretin Dependence of GPR119-Mediated Glucoregulation. 
  • β-Cell Sensitivity to GLP-1 in Healthy Humans Is Variable and Proportional to Insulin Sensitivity. 
  • β-cell dysfunction in adolescents and adults with newly diagnosed type 2 diabetes mellitus. 
• 

  Keywords of People

  • Baugh, L. Ryan, Associate Professor of Biology, Biology
  • Bennett, Vann, George Barth Geller Distinguished Professor of Molecular Biology, Duke Cancer Institute
  • Carbrey, Jennifer Mehlman, Assistant Research Professor of Cell Biology, Cell Biology
  • Freemark, Michael Scott, Robert C. Atkins, M.D. and Veronica Atkins Distinguished Professor of Pediatrics, in the School of Medicine, Pediatrics, Endocrinology
  • Grambow, Steven C., Associate Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Humphreys, Margaret Ellen, Josiah Charles Trent Distinguished Professor of the History of Medicine, in the School of Medicine, Duke Science & Society
  • Muir, Kelly Walton, Associate Professor of Ophthalmology, Ophthalmology, Glaucoma
  • Pitt, Geoffrey Stuart, Adjunct Professor in the Department of Medicine, Medicine, Cardiology
  • Soderling, Scott Haydn, George Barth Geller Distinguished Professor of Molecular Biology, Cell Biology
  • Yancy Jr., William Samuel, Professor of Medicine, Medicine, General Internal Medicine